Founders Capital Management (Texas)’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,900
| Closed | -$12K | – | 328 |
|
|
2021
Q3 | $12K | Buy |
1,900
+900
| +90% | +$5.68K | 0.01% | 263 |
|
|
2021
Q2 | $8K | Hold |
1,000
| – | – | 0.01% | 274 |
|
|
2021
Q1 | $9K | Hold |
1,000
| – | – | 0.01% | 255 |
|
|
2020
Q4 | $12K | Buy |
+1,000
| New | +$12K | 0.01% | 235 |
|
|
2020
Q1 | $8K | Hold |
1,000
| – | – | 0.01% | 241 |
|
|
2019
Q4 | $21K | Hold |
1,000
| – | – | 0.02% | 174 |
|
|
2019
Q3 | $14K | Hold |
1,000
| – | – | 0.01% | 228 |
|
|
2019
Q2 | $12K | Hold |
1,000
| – | – | 0.01% | 245 |
|
|
2019
Q1 | $12K | Buy |
1,000
+300
| +43% | +$3.6K | 0.01% | 241 |
|
|
2018
Q4 | $8K | Hold |
700
| – | – | 0.01% | 258 |
|
|
2018
Q3 | $13K | Hold |
700
| – | – | 0.01% | 224 |
|
|
2018
Q2 | $18K | Buy |
700
+200
| +40% | +$5.14K | 0.02% | 203 |
|
|
2018
Q1 | $11K | Hold |
500
| – | – | 0.01% | 282 |
|
|
2017
Q4 | $13K | Buy |
+500
| New | +$13K | 0.01% | 261 |
|